Role of Patients and Parents in Pediatric Drug Development

Vivian W L Tsang1, Leanne West2, Christine Woods3

  • 11 Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.

Insights

Pediatric patients and families are crucial experts in healthcare, yet their input is often missing in pediatric clinical trials and drug development. This review highlights best practices for incorporating their voices to improve child health outcomes.

Area of Science:

  • Pediatric Health Research
  • Clinical Trial Methodology
  • Patient Engagement

Background:

  • Patient engagement is increasingly recognized as vital in healthcare, with patients viewed as experts in their own conditions.
  • Historically, pediatric patients' and families' input has been undervalued in pediatric clinical trial design and outcome assessment.
  • This gap is particularly concerning in pediatric drug development, leading to off-label prescribing and adverse events.

Purpose of the Study:

  • To review current best practices for involving pediatric patients and families in drug development.
  • To examine progress made by regulatory agencies in including children and youth in clinical trials.
  • To highlight global advocacy efforts aimed at amplifying the voices of children and youth in pharmaceutical research.

Main Methods:

  • International expert review of current best practices.
  • Analysis of regulatory agency progress and legislative changes in North America and Europe.
  • Examination of global patient advocacy and advisory group initiatives.

Main Results:

  • Despite legislative advancements, systematic guidelines for incorporating pediatric patient input are lacking.
  • Pediatric advocacy groups play a key role in advancing patient involvement.
  • International experts convened to discuss and review progress.

Conclusions:

  • Incorporating pediatric patient and family perspectives early in drug development is essential.
  • Systematic methodologies and guidelines are needed to overcome barriers to practical application.
  • Valuing the voice of children and youth is critical for future pediatric drug development and improved health outcomes.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
259
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
223
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
292
Parental Care00:55

Parental Care

Many animals exhibit parental care behavior, including feeding, grooming, and protecting young offspring. Parental care is universal in mammals and birds, which often have young that are born relatively helpless. Several species of insects and fish, as well as some amphibians, also care for their young.
12.7K
Parenting Styles01:27

Parenting Styles

Diana Baumrind's four parenting styles — authoritarian, authoritative, neglectful, and permissive — each influence children's socio-emotional development differently.
Authoritarian Parenting
This style is strict and controlling, with little room for open dialogue. Authoritarian parents demand obedience and often enforce rules with minimal warmth. Children raised this way may lack social skills and initiative, usually comparing themselves to others unfavorably.
Authoritative...
669